收藏切换
Study on the safety, tolerance and pharmacokinetics of recombinant human parathyroid hormone 1-84 after single and continuous administration
收藏切换
PDF
Ning ZHANG1, Wei-yi CAO2, Ming-jie ZI2, Shu-ge WANG2, Ying-pan ZHAO2, Fang LU2, Rui GAO2, Chun YANG3, Lin-hong ZHANG3, Xin-lei GUO3, Rui LI2, *
Chinese Journal of New Drugs | 2025, 34(17) : 1820 - 1825
Less
收藏切换
Chinese Journal of New Drugs | 2025, 34(17): 1820-1825
Study on the safety, tolerance and pharmacokinetics of recombinant human parathyroid hormone 1-84 after single and continuous administration
Full
Ning ZHANG1, Wei-yi CAO2, Ming-jie ZI2, Shu-ge WANG2, Ying-pan ZHAO2, Fang LU2, Rui GAO2, Chun YANG3, Lin-hong ZHANG3, Xin-lei GUO3, Rui LI2, *
Affiliations
  • 1Graduate School of Beijing University of Chinese Medicine, Beijing 100029, China
  • 2Institute of Clinical Pharmacology of Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China
  • 3Sichuan Luzhou Buchang BIO-Pharmaceutical Co.,Ltd., Luzhou 646000, China
Published: 2025-09-15 doi: 10.20251/j.cnki.1003-3734.2025.17.005
Outline
收藏切换
Objective:

To evaluate the safety and tolerance of a single administration versus multiple administrations of recombinant human parathyroid hormone 1-84 (PTH1-84) for injection in Chinese healthy volunteers, as well as to observe the pharmacokinetic characteristics in health individuals following drug administration.

Methods:

A single center, open, single administration/multiple administration trial was designed. The healthy subjects were divided into four dose groups: 25, 50, 75 and 100 μg, in which the 25 μg dose group was only given at a single dose, and the other three dose groups continued to conduct continuous administration after a single dose. The physical signs of the subjects were recorded, and the biological samples were collected at the time specified in the scheme to calculate and analyze the pharmacokinetic parameters. The safety of different doses of recombinant PTH1-84 was evaluated by the pharmacokinetic parameters of healthy subjects and the occurrence of adverse reactions.

Results:

A total of 28 healthy subjects were included in the study, with 4 participants in the 25 μg dosage group and 8 participants in each of the remaining three groups. In the safety evaluation, no correlation between the incidence of adverse events and dosages was observed, and no serious adverse events occurred. The reported adverse reactions resolved favorably. The pharmacokinetic results indicate that recombinant human parathyroid hormone 1-84, within the dosage range of 50 to 100 μg, demonstrates a dose-dependent relationship for both AUC and Cmax following single and multiple administrations. This suggests a positive correlation between drug exposure and dosage.

Conclusion:

PTH1-84 has good clinical safety and tolerance at the experimental dose.

recombinant human parathyroid hormone 1-84  /  phase I clinical study  /  pharmacokinetic  /  safety  /  tolerance
Ning ZHANG, Wei-yi CAO, Ming-jie ZI, Shu-ge WANG, Ying-pan ZHAO, Fang LU, Rui GAO, Chun YANG, Lin-hong ZHANG, Xin-lei GUO, Rui LI. Study on the safety, tolerance and pharmacokinetics of recombinant human parathyroid hormone 1-84 after single and continuous administration[J]. Chinese Journal of New Drugs, 2025 , 34 (17) : 1820 -1825 . DOI: 10.20251/j.cnki.1003-3734.2025.17.005
Year 2025 volume 34 Issue 17
PDF
128
60
Cite this Article
BibTeX
Article Info
doi: 10.20251/j.cnki.1003-3734.2025.17.005
  • Online Date:2026-03-06
  • Published:2025-09-15
Article Data
Affiliations
History
  • Accepted:2025-05-25
Funding
Affiliations
    1Graduate School of Beijing University of Chinese Medicine, Beijing 100029, China
    2Institute of Clinical Pharmacology of Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China
    3Sichuan Luzhou Buchang BIO-Pharmaceutical Co.,Ltd., Luzhou 646000, China
References
Share
https://castjournals.cast.org.cn/joweb/zgxyzz/EN/10.20251/j.cnki.1003-3734.2025.17.005
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT